#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous calcification Ovarian cancer stage III Squamous cell carcinoma of head and neck Langerhans cell sarcoma Hairy cell leukaemia Myasthenia gravis Pemphigoid Small cell lung cancer Malignant peritoneal neoplasm Rhabdomyosarcoma Richter's syndrome Autoimmune haemolytic anaemia Stevens-Johnson syndrome Choroidal dystrophy Cutaneous T-cell lymphoma stage I More trials…

    Learn about Rare Diseases

    Malignant fibrous histiocytoma – Trials in Disease Hereditary optic atrophy Advanced systemic mastocytosis – Trials in Disease Osteosarcoma recurrent – Basic Information Haemophilia – Basic Information Stevens-Johnson syndrome – Trials in Disease Metachromatic leukodystrophy – Life with Disease Rhabdoid tumour Sarcoidosis – Treatment Small intestine leiomyosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Florquinitau (18F) Cart45Ra-Nkg2D Cells Av-Ec2023 Xevinapant INSULIN DEGLUDEC Tyrosine Betamethasone Dipropionate Cobolimab Abc-24F-116 Pyruvic Acid Paclitaxel Obaluronate Valoctocogene Roxaparvovec Insulin Human (Rdna) Mycophenolate Mofetil Apitegromab Desvenlafaxine Benzoate L-Arginine Hydrochloride Gen1055 Navitoclax Omalizumab More therapies…

    Learn about Your Condition

    Impaired gastric emptying Neurotrophic keratopathy Stargardt's disease Coma Familial hypertriglyceridaemia Colon cancer Acute leukaemia Polycystic liver disease C3 glomerulopathy Catatonia Chronic hepatic failure Medulloblastoma Migraine without aura Adrenal insufficiency Pneumonia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Interstitial lung disease

  • Long‑term Safety and Tolerability of Admilparant in Adults with Idiopathic or Progressive Pulmonary Fibrosis

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • ADMILPARANT
    Austria Belgium Denmark Finland France Germany +8

  • Carboplatin‑based drug combination for advanced non‑small cell lung cancer patients with interstitial lung disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Interstitial lung disease
    • Non-small cell lung cancer stage IIIB
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Vinorelbine
    • Bevacizumab
    • Carboplatin
    France

  • Study of tezepelumab in patients with progressive pulmonary fibrosis and increased eosinophil levels in blood

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Interstitial lung disease
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Tezepelumab
    Germany

  • Study on the Effects of High-Flow Oxygen Therapy in Patients with Interstitial Lung Disease During Exercise

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Interstitial lung disease
    Investigated Drugs:
    • Oxygen
    Spain

  • Study on Pirfenidone Inhalation Solution for Patients with Progressive Fibrosing Interstitial Lung Diseases, Including Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Interstitial lung disease
    Investigated Drugs:
    • Pirfenidone
    Czechia The Netherlands Poland

  • Study on the Long-Term Safety of Nintedanib for Children and Adolescents with Interstitial Lung Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Interstitial lung disease
    Investigated Drugs:
    • Nintedanib
    Belgium Czechia France Greece Italy Norway +2
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!